24/01/2006
Amgen To Create 1,100 New Jobs In Cork
Amgen, the largest biotechnology company in the world, has chosen Ireland for major new development and manufacturing investments that promise up to 1,100 jobs by 2010.
Supported by IDA Ireland, Amgen plans to invest more than $1 billion (€0.82 billion) in a major facility at Carrigtwohill in Co. Cork.
The pharmaceutical company discovers and develops innovative human therapeutic products for patients and has pioneered significant medical developments in the fight against cancer, kidney disease, rheumatoid arthritis and other serious illnesses.
The proposed Irish operations will manufacture products for the growing number of patients in Europe and other parts of the world who benefit from the company’s vital medicines.
The projects will get underway later in 2006 at a 133-acre green field site and operations are expected to begin in 2009.
Minister for Enterprise, Trade and Employment Micheál Martin said: “This is a landmark decision and one which is welcomed not just by Cork but by all of Ireland. Investments of this scale speak volumes about Ireland’s ability to compete and win the most advanced and innovative business from the biggest biotechnology company in the world.
"The intense global competition for these investments has been well publicised and we are delighted to be officially bringing this superb news today to the people of Cork and Ireland."
Minister Martin said the investment further validated the decisions by the Government over recent years to invest in the development of Ireland’s support infrastructure for the Biotechnology industry.
He said: "The investment, through Science Foundation Ireland, in biotechnology research in our universities and the more recent decision to establish the National Institute of Bioprocessing Research and Training are initiatives which have improved our competitiveness and will provide substantive support to Amgen as it grows and develops its business here in Ireland.”
Dr. Fabrizio Bonanni, Senior Vice President of Manufacturing, Amgen, said “Amgen is delighted to be establishing in Ireland as part of our ongoing global development and manufacturing expansion. As demand for our products continued to grow in Europe, our company recognised the need for capacity closer to this important market.
"We considered several attractive sites in other countries for these projects and finally chose Ireland due to its thriving biotechnology community, infrastructure to support biologics manufacturing and pro-business environment. In addition, the access and availability to highly skilled and educated people particularly in the areas we most require combined with the support and assistance of IDA Ireland made this decision the right one for Amgen’s future”.
Worldwide Amgen employs 14,000 people of whom over 5,500 are employed in R&D.
The Carrigtwohill plant will include development, bulk manufacturing, fill, and finish facilities.
(SP)
Supported by IDA Ireland, Amgen plans to invest more than $1 billion (€0.82 billion) in a major facility at Carrigtwohill in Co. Cork.
The pharmaceutical company discovers and develops innovative human therapeutic products for patients and has pioneered significant medical developments in the fight against cancer, kidney disease, rheumatoid arthritis and other serious illnesses.
The proposed Irish operations will manufacture products for the growing number of patients in Europe and other parts of the world who benefit from the company’s vital medicines.
The projects will get underway later in 2006 at a 133-acre green field site and operations are expected to begin in 2009.
Minister for Enterprise, Trade and Employment Micheál Martin said: “This is a landmark decision and one which is welcomed not just by Cork but by all of Ireland. Investments of this scale speak volumes about Ireland’s ability to compete and win the most advanced and innovative business from the biggest biotechnology company in the world.
"The intense global competition for these investments has been well publicised and we are delighted to be officially bringing this superb news today to the people of Cork and Ireland."
Minister Martin said the investment further validated the decisions by the Government over recent years to invest in the development of Ireland’s support infrastructure for the Biotechnology industry.
He said: "The investment, through Science Foundation Ireland, in biotechnology research in our universities and the more recent decision to establish the National Institute of Bioprocessing Research and Training are initiatives which have improved our competitiveness and will provide substantive support to Amgen as it grows and develops its business here in Ireland.”
Dr. Fabrizio Bonanni, Senior Vice President of Manufacturing, Amgen, said “Amgen is delighted to be establishing in Ireland as part of our ongoing global development and manufacturing expansion. As demand for our products continued to grow in Europe, our company recognised the need for capacity closer to this important market.
"We considered several attractive sites in other countries for these projects and finally chose Ireland due to its thriving biotechnology community, infrastructure to support biologics manufacturing and pro-business environment. In addition, the access and availability to highly skilled and educated people particularly in the areas we most require combined with the support and assistance of IDA Ireland made this decision the right one for Amgen’s future”.
Worldwide Amgen employs 14,000 people of whom over 5,500 are employed in R&D.
The Carrigtwohill plant will include development, bulk manufacturing, fill, and finish facilities.
(SP)
Related Northern Ireland Recruitment News Stories
Click here for the latest headlines.
11 December 2017
Projects Across Ireland Secure Enterprise Funding
Twenty-one projects from across Ireland have secured up to €30.5 million in the first competitive call of the Regional Enterprise Development Fund. Minister for Business, Enterprise and Innovation, Heather Humphreys TD, announced the results of the first round of the new €60m fund.
Projects Across Ireland Secure Enterprise Funding
Twenty-one projects from across Ireland have secured up to €30.5 million in the first competitive call of the Regional Enterprise Development Fund. Minister for Business, Enterprise and Innovation, Heather Humphreys TD, announced the results of the first round of the new €60m fund.
18 July 2011
Wind Turbines Blow In Jobs
A leading Irish manufacturing company is to create 145 new jobs in Athenry, County Galway over the next three years. Taoiseach Enda Kenny said that Enterprise Ireland has made a significant investment in C&F Green Energy Limited and is providing employment grants to support the employment of the 145 new employees.
Wind Turbines Blow In Jobs
A leading Irish manufacturing company is to create 145 new jobs in Athenry, County Galway over the next three years. Taoiseach Enda Kenny said that Enterprise Ireland has made a significant investment in C&F Green Energy Limited and is providing employment grants to support the employment of the 145 new employees.
19 September 2016
Hundreds Of New Jobs To Be Created In Cork
Up to 500 permanent and 800 temporary jobs are to be created in Cork with the establishment of a new biopharmaceutical manufacturing campus.
Hundreds Of New Jobs To Be Created In Cork
Up to 500 permanent and 800 temporary jobs are to be created in Cork with the establishment of a new biopharmaceutical manufacturing campus.
04 September 2014
Magellan Aerospace To Create 47 New Jobs
Enterprise, Trade and Investment Minister Arlene Foster has announced that Magellan Aerospace is investing almost £6million in its Greyabbey operation and creating 47 advanced manufacturing jobs. The Canadian-owned Magellan Aerospace established its presence in Northern Ireland in 2012 when it acquired local company John Huddleston Engineering Ltd.
Magellan Aerospace To Create 47 New Jobs
Enterprise, Trade and Investment Minister Arlene Foster has announced that Magellan Aerospace is investing almost £6million in its Greyabbey operation and creating 47 advanced manufacturing jobs. The Canadian-owned Magellan Aerospace established its presence in Northern Ireland in 2012 when it acquired local company John Huddleston Engineering Ltd.
26 July 2012
Sangart Announces Plans For New Manufacturing Facility In Ireland
Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced plans to build a new manufacturing facility in Ireland.
Sangart Announces Plans For New Manufacturing Facility In Ireland
Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced plans to build a new manufacturing facility in Ireland.